C21 Investments Inc (CXXIF)
0.2385
+0.02
(+8.41%)
USD |
OTCM |
Sep 19, 16:00
C21 Investments Market Cap: 28.63M for Sept. 19, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| September 19, 2024 | 28.63M |
| September 18, 2024 | 26.41M |
| September 17, 2024 | 28.21M |
| September 16, 2024 | 28.81M |
| September 13, 2024 | 28.76M |
| September 12, 2024 | 26.41M |
| September 11, 2024 | 30.01M |
| September 10, 2024 | 30.25M |
| September 09, 2024 | 30.25M |
| September 06, 2024 | 27.01M |
| September 05, 2024 | 29.71M |
| September 04, 2024 | 29.89M |
| September 03, 2024 | 28.81M |
| August 30, 2024 | 27.47M |
| August 29, 2024 | 27.01M |
| August 28, 2024 | 27.61M |
| August 27, 2024 | 25.82M |
| August 26, 2024 | 28.03M |
| August 23, 2024 | 29.63M |
| August 22, 2024 | 27.61M |
| August 21, 2024 | 28.33M |
| August 20, 2024 | 28.93M |
| August 19, 2024 | 32.89M |
| August 16, 2024 | 31.21M |
| August 15, 2024 | 28.09M |
| Date | Value |
|---|---|
| August 14, 2024 | 32.41M |
| August 13, 2024 | 27.93M |
| August 12, 2024 | 27.01M |
| August 09, 2024 | 28.99M |
| August 08, 2024 | 31.06M |
| August 07, 2024 | 30.01M |
| August 06, 2024 | 32.71M |
| August 05, 2024 | 30.01M |
| August 02, 2024 | 29.53M |
| August 01, 2024 | 33.31M |
| July 31, 2024 | 33.73M |
| July 30, 2024 | 37.82M |
| July 29, 2024 | 33.49M |
| July 26, 2024 | 31.44M |
| July 25, 2024 | 30.01M |
| July 24, 2024 | 30.01M |
| July 23, 2024 | 33.21M |
| July 22, 2024 | 31.21M |
| July 19, 2024 | 28.85M |
| July 18, 2024 | 32.41M |
| July 17, 2024 | 32.41M |
| July 16, 2024 | 32.23M |
| July 15, 2024 | 30.01M |
| July 12, 2024 | 29.83M |
| July 11, 2024 | 30.06M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
14.75M
Minimum
Mar 18 2020
230.60M
Maximum
Feb 11 2021
55.66M
Average
38.90M
Median
Feb 17 2023
Market Cap Benchmarks
| Acasti Pharma Inc | 29.20M |
| Aurinia Pharmaceuticals Inc | 1.030B |
| Edesa Biotech Inc | 14.13M |
| Lexaria Bioscience Corp | 49.80M |
| Xenon Pharmaceuticals Inc | 3.100B |
Market Cap Related Metrics
| PS Ratio | 1.059 |
| PEG Ratio | -0.0036 |
| Price to Book Value | 0.9248 |
| Price to Free Cash Flow | 22.89 |
| Price | 0.2385 |
| Earnings Yield | -15.35% |
| PEGY Ratio | -0.0036 |
| Operating PE Ratio | 375.07 |